Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Keefe, R. S.E. Articles by Harvey, P. D. Search for Related Content PubMed Citation Articles by Keefe, R. S.E. Articles by Harvey, P. D. Alzheimer's Disease Schizophrenia Spectrum Disorders Interviews Cognition

The Schizophrenia Cognition Rating Scale: An Interview-Based Assessment and Its Relationship to Cognition, Real-World Functioning, and Functional Capacity

OBJECTIVE: Interview-based measures of cognition may serve as potential coprimary measures in clinical trials of cognitive-enhancing drugs for schizophrenia. However, there is no such valid scale available. Interviews of patients and their clinicians are not valid in that they are unrelated to patients’ levels of cognitive impairment as assessed by cognitive performance tests. This study describes the reliability and validity of a new interview-based assessment of cognition, the Schizophrenia Cognition Rating Scale (SCoRS), that involves interviews with patients and informants. METHOD: Sixty patients with schizophrenia were assessed with the SCoRS and three potential validators of an interview-based measure of cognition: cognitive performance, as measured by the Brief Assessment of Cognition in Schizophrenia (BACS); real-world functioning, as measured by the Independent Living Skills Inventory; and functional capacity, as measured by the University of California, San Diego, Performance-Based Skills Assessment (UPSA). RESULTS: The SCoRS global ratings were significantly correlated with composite scores of cognitive performance and functional capacity and with ratings of real-world functioning. Multiple regression analyses suggested that SCoRS global ratings predicted unique variance in real-world functioning beyond that predicted by the performance measures. CONCLUSIONS: An interview-based measure of cognition that included informant reports was related to cognitive performance as well as real-world functioning. Interview-based measures of cognition, such as the SCoRS, may be valid coprimary measures for clinical trials assessing cognitive change and may also aid clinicians desiring to assess patients’ level of cognitive impairment.

This article has been cited by other articles:

				M. F. Green, K. H. Nuechterlein, R. S. Kern, L. E. Baade, W. S. Fenton, J. M. Gold, R. S.E. Keefe, R. Mesholam-Gately, L. J. Seidman, E. Stover, et al. Functional Co-Primary Measures for Clinical Trials in Schizophrenia: Results From the MATRICS Psychometric and Standardization Study Am J Psychiatry, February 1, 2008; 165(2): 221 - 228. [Abstract] [Full Text] [PDF]

				A. Medalia and J. Thysen Insight Into Neurocognitive Dysfunction in Schizophrenia Schizophr Bull, January 16, 2008; (2008) sbm144v1. [Abstract] [Full Text] [PDF]

				P. D. Harvey, D. I. Velligan, and A. S. Bellack Performance-Based Measures of Functional Skills: Usefulness in Clinical Treatment Studies Schizophr Bull, September 1, 2007; 33(5): 1138 - 1148. [Abstract] [Full Text] [PDF]

				M. S. Kraus and R. S. E. Keefe Cognition as an outcome measure in schizophrenia The British Journal of Psychiatry, August 1, 2007; 191(50): s46 - s51. [Abstract] [Full Text] [PDF]

				R. S. E. Keefe and W. S. Fenton How Should DSM-V Criteria for Schizophrenia Include Cognitive Impairment? Schizophr Bull, July 1, 2007; 33(4): 912 - 920. [Abstract] [Full Text] [PDF]

				A. S. Bellack, M. F. Green, J. A. Cook, W. Fenton, P. D. Harvey, R. K. Heaton, T. Laughren, A. C. Leon, D. J. Mayo, D. L. Patrick, et al. Assessment of Community Functioning in People With Schizophrenia and Other Severe Mental Illnesses: A White Paper Based on an NIMH-Sponsored Workshop Schizophr Bull, May 1, 2007; 33(3): 805 - 822. [Abstract] [Full Text] [PDF]

				E. Bromley Clinicians' Concepts of the Cognitive Deficits of Schizophrenia Schizophr Bull, May 1, 2007; 33(3): 648 - 651. [Abstract] [Full Text] [PDF]

				E. Bromley Barriers to the Appropriate Clinical Use of Medications That Improve the Cognitive Deficits of Schizophrenia Psychiatr Serv, April 1, 2007; 58(4): 475 - 481. [Abstract] [Full Text] [PDF]

				D. L. Hake, E. Hamera, and M. Rempfer Self-report of Cognitive Functioning and Learning in Schizophrenia Journal of the American Psychiatric Nurses Association, April 1, 2007; 13(2): 93 - 100. [Abstract] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us